Type 1 Diabetes Drugs Price Analysis and Strategies 2016-2021 - Research and Markets

DUBLIN, Feb 23, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Type 1 Diabetes Drugs Price Analysis and Strategies - 2016" report to their offering.

The latest research Type 1 Diabetes Drugs Price Analysis and Strategies - 2016, provides drug pricing data and benchmarks in the global Type 1 Diabetes market.

The research answers the following questions:

• What are the key drugs marketed for Type 1 Diabetes and their clinical attributes? How are they positioned in the Global Type 1 Diabetes market?
• What are the unit prices and annual treatment cost for Type 1 Diabetes therapies in different countries? What are the drug pricing trends and how are they expected to change in the future? How are the drug pricing and reimbursement landscape different by countries?
• What are the unmet needs in the global Type 1 Diabetes drugs market? What would be the ideal pricing strategy for a new pipeline therapy for Type 1 Diabetes?

Research Scope:

• Type 1 Diabetes Treatment Options - Identify key drugs marketed and prescribed for Type 1 Diabetes in the US, Germany, France, Italy, Spain, UK, Japan including trade name, molecule name, and company
• Type 1 Diabetes Drugs Attributes - Find out the safety, efficacy, and risk benefit for key drugs marketed for Type 1 Diabetes
• Market Positioning - Identify how drugs are clinically and commercially positioned in the global Type 1 Diabetes market
• Type 1 Diabetes Drugs Price Analysis - Find out the annual therapy cost and unit price for key drugs marketed for Type 1 Diabetes in the US, Germany, France, Italy, Spain, UK, Japan. Find out how the price advanced from 2012 and forecast to 2021
• Pricing & Reimbursement Landscape - Find out the pricing and reimbursement landscape in the US, Germany, France, Italy, Spain, UK, Japan
• Type 1 Diabetes New Drug Pricing - Identify the effective pricing strategy for a new drug launch in the US, Germany, France, Italy, Spain, UK, Japan

This research will help executives

• Identify clinical attributes of your competitor drugs
• Find out how the marketed products for Type 1 Diabetes are clinically and commercially positioned
• Understand the price of your competitor drugs by countries
• Use Type 1 Diabetes drugs price data for market sizing, drug sales forecast, budgeting, competitive intelligence, HEOR, and reimbursement
• Find out the pricing and reimbursement landscape by countries
• Identify the unmet need in global Type 1 Diabetes market
• Identify the effective pricing for a new drug

For more information about this report visit http://www.researchandmarkets.com/research/dj33nx/type_1_diabetes

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]